Table 5.
Overall survival and progression free survival in univariate and multivariate analysis (Cox Regression Analysis)
| Overall survival | Progression free survival | Overall survival | Progression free survival | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Univariate | Univariate | Multivariate | Multviariate | |||||||||
| HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | |
| All patients with known histology (N = 326) | ||||||||||||
| Advanced stage | 8.1 | 4.7–14.1 | <0.001 | 5.9 | 3.9–8.9 | <0.001 | 4.6 | 1.8–12.2 | 0.002 | 2.8 | 1.4–5.4 | 0.003 |
| Age ≥58 years | 1.7 | 1.2–2.2 | 0.001 | 1.5 | 1.1–1.9 | 0.006 | 1.1 | 0.8–1.6 | 0.5 | 1.0 | 0.7–1.4 | 0.8 |
| Serous type | 0.3 | 0.2–0.5 | <0.001 | 0.3 | 0.2–0.4 | <0.001 | 1.8 | 1.1–3.1 | 0.03 | 2.0 | 1.2–3.4 | 0.008 |
| Residual disease ≥2 cm | 4.6 | 3.3–6.4 | <0.001 | 4.6 | 3.4–6.4 | <0.001 | 2.3 | 1.5–3.4 | <0.001 | 2.4 | 1.6–3.6 | <0.001 |
| Grade III/undifferentiated | 2.8 | 2.0–3.9 | <0.001 | 2.7 | 2.0–3.6 | <0.001 | 0.7 | 0.5–1.1 | 0.1 | 0.8 | 0.6–1.3 | 0.008 |
| FR-α overexpression | 1.2 | 0.8–1.7 | 0.5 | 1.2 | 0.8–1.7 | 0.3 | 0.8 | 0.5–1.1 | 0.2 | 0.8 | 0.5–1.2 | 0.2 |